Anhui Huaren Health Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Huaren Health Pharmaceutical Co., Ltd.

Why is Anhui Huaren Health Pharmaceutical Co., Ltd. ?

With a growth in Net Profit of 51.56%, the company declared Very Positive results in Sep 25

OPERATING CASH FLOW(Y) Highest at CNY 772.77 MM
NET PROFIT(HY) At CNY 95.5 MM has Grown at 58.73%
RAW MATERIAL COST(Y) Fallen by -3.16% (YoY)

With ROE of 9.01%, it has a very attractive valuation with a 0.35 Price to Book Value

Over the past year, while the stock has generated a return of 39.70%, its profits have risen by 32% ; the PEG ratio of the company is 0.1

Market Beating Performance

The stock has generated a return of 39.70% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.45%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Anhui Huaren Health Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Anhui Huaren Health Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Anhui Huaren Health Pharmaceutical Co., Ltd.

-100.0%

0.72

66.79%

China Shanghai Composite

16.01%

1.03

14.98%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

22.26%

EBIT Growth (5y)

34.65%

EBIT to Interest (avg)

32.23

Debt to EBITDA (avg)

0.98

Net Debt to Equity (avg)

0.37

Sales to Capital Employed (avg)

1.14

Tax Ratio

25.02%

Dividend Payout Ratio

29.05%

Pledged Shares

Institutional Holding

ROCE (avg)

10.04%

ROE (avg)

7.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.35

EV to EBIT

7.75

EV to EBITDA

3.36

EV to Capital Employed

0.60

EV to Sales

0.41

PEG Ratio

0.12

Dividend Yield

ROCE (Latest)

7.72%

ROE (Latest)

9.01%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 772.77 MM

NET PROFIT(HY)

At CNY 95.5 MM has Grown at 58.73%

RAW MATERIAL COST(Y)

Fallen by -3.16% (YoY

NET SALES(Q)

Highest at CNY 1,388.56 MM

PRE-TAX PROFIT(Q)

At CNY 74.84 MM has Grown at 62.16%

-8What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 70.76 %

INTEREST(Q)

At CNY 4.79 MM has Grown at 180.68%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,637.03

OPERATING PROFIT(Q)

Lowest at CNY 78.36 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 5.64 %

Here's what is working for Anhui Huaren Health Pharmaceutical Co., Ltd.

Net Profit

At CNY 95.5 MM has Grown at 58.73%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 772.77 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 1,388.56 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 1,388.56 MM has Grown at 26.64%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 74.84 MM has Grown at 62.16%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Raw Material Cost

Fallen by -3.16% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Anhui Huaren Health Pharmaceutical Co., Ltd.

Interest

At CNY 4.79 MM has Grown at 180.68%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,637.03

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at 70.76 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit

Lowest at CNY 78.36 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 5.64 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales